Observe the effects of treatment on clinical parameters indicative of mucositis or peri-implantitis (Δ PD; Δ PI; Δ BoP) and/or immunological parameters (Δ IL-1β; Δ IL-6; Δ IL-8; TNF-α). This evidence concerns the gene IL1B and mucositis.